Table 1.
GST Specific activity against 1-chloro-2,4-dinitrobenzene, CDNB (Specific activity expressed as units/mg protein)
| Samples | Stomach | Intestine | Liver | Lung |
|---|---|---|---|---|
| Control | 0.728 ± 0.05 | 1.260 ± 0.13 | 2.520 ± 0.11 | 0.399 ± 0.07 |
| Mixture | 0.757 ± 0.02 | 1.191 ± 0.11 | 1.833 ± 0.26* | 0.414 ± 0.02 |
| Nomilin | 1.152 ± 0.16** | 1.122 ± 0.24 | 2.223 ± 0.39 | 0.395 ± 0.01 |
| Deacetyl nomilin | 0.872 ± 0.09** | 0.715 ± 0.18* | 1.582 ± 0.24* | 0.449 ± 0.01 |
| Isoobacunoic Acid | 0.914 ± 0.13** | 0.825 ± 0.84 | 1.390 ± 0.02* | 0.365 ± 0.01 |
Results are means ± SD (n = 4)
* indicates statistically significant (p < 0.05) reduction of activity.
** indicates statistically significant (p < 0.01) induction of activity.